Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)

TPE:1720 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,520	2,037	2,259	2,564	1,036
Short-Term Investments	134.5	60.5	44.36	57.84	308.54
Trading Asset Securities	157.36	178.29	176.15	134.91	136.56
Cash & Short-Term Investments	1,812	2,276	2,480	2,757	1,481
Cash Growth	-20.37%	-8.24%	-10.06%	86.13%	-12.46%
Accounts Receivable	1,323	1,263	1,263	1,158	942.84
Other Receivables	17.29	155.84	216.67	331.82	24.41
Receivables	1,340	1,419	1,480	1,490	967.25
Inventory	1,720	1,615	1,386	1,218	893.51
Prepaid Expenses	126.91	103.09	95.21	86.62	93.16
Other Current Assets	2.49	5.56	148.27	232.89	166.39
Total Current Assets	5,002	5,418	5,589	5,784	3,602
Property, Plant & Equipment	4,389	4,301	3,952	2,955	2,389
Long-Term Investments	1,208	967.73	844.45	769.34	669.49
Goodwill	173.91	173.91	173.91	162.24	70.27
Other Intangible Assets	33.82	40.63	51.08	61.38	18.7
Long-Term Deferred Tax Assets	132.26	141.31	128.37	141.45	138.59
Other Long-Term Assets	236.25	146.82	228.68	221.04	161.53
Total Assets	11,176	11,189	10,968	10,095	7,049
Accounts Payable	603.07	642.99	686.37	624.35	438.57
Accrued Expenses	332.43	340.88	290.57	141.95	-
Short-Term Debt	110	800	1,350	1,358	566
Current Portion of Long-Term Debt	59.03	59.03	-	-	-
Current Portion of Leases	23.75	24.17	21.21	20.35	17.54
Current Income Taxes Payable	195.82	235.19	222.04	164.07	99.09
Current Unearned Revenue	94.99	83.21	84	79.12	135.66
Other Current Liabilities	241.85	185.41	225.65	328.28	393.76
Total Current Liabilities	1,661	2,371	2,880	2,716	1,651
Long-Term Debt	163.95	222.97	182	50	-
Long-Term Leases	203.7	221.72	236.7	239.64	201.66
Long-Term Deferred Tax Liabilities	85.49	84.27	84.67	83.85	61.99
Other Long-Term Liabilities	8.77	12.3	0.41	0.53	1.37
Total Liabilities	2,199	3,051	3,533	3,295	2,144
Common Stock	1,787	1,787	1,787	1,787	1,787
Additional Paid-In Capital	300.13	223.89	220.48	204.31	203.27
Retained Earnings	3,710	3,275	2,862	2,461	1,946
Comprehensive Income & Other	108.13	13.18	-115.94	-110.33	29.31
Total Common Equity	5,905	5,299	4,753	4,342	3,966
Minority Interest	3,071	2,838	2,682	2,458	939.9
Shareholders' Equity	8,976	8,137	7,436	6,800	4,906
Total Liabilities & Equity	11,176	11,189	10,968	10,095	7,049
Total Debt	560.43	1,328	1,790	1,668	785.2
Net Cash (Debt)	1,252	947.65	689.98	1,089	696.09
Net Cash Growth	32.07%	37.34%	-36.65%	56.47%	3.94%
Net Cash Per Share	7.00	5.30	3.86	6.09	3.89
Filing Date Shares Outstanding	178.7	178.7	178.7	178.7	178.7
Total Common Shares Outstanding	178.7	178.7	178.7	178.7	178.7
Working Capital	3,341	3,047	2,710	3,068	1,951
Book Value Per Share	33.05	29.65	26.60	24.30	22.19
Tangible Book Value	5,697	5,084	4,528	4,118	3,877
Tangible Book Value Per Share	31.88	28.45	25.34	23.05	21.70
Land	898.54	770.54	770.54	496.34	420.37
Buildings	2,421	2,190	2,055	1,819	1,671
Machinery	3,940	3,738	3,196	2,738	2,168
Construction In Progress	206.52	345.85	385.15	171.35	86.34

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.